IRIS
LEONCINI, GIOVANNA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 13.559
AS - Asia 1.219
NA - Nord America 468
SA - Sud America 114
AF - Africa 19
OC - Oceania 5
Totale 15.384
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 13.321
SG - Singapore 587
US - Stati Uniti d'America 442
CN - Cina 342
VN - Vietnam 179
FR - Francia 107
BR - Brasile 71
HK - Hong Kong 38
FI - Finlandia 29
DE - Germania 27
AR - Argentina 21
CH - Svizzera 21
IQ - Iraq 15
GB - Regno Unito 12
JP - Giappone 12
MX - Messico 10
NL - Olanda 10
BD - Bangladesh 9
IN - India 8
CA - Canada 7
VE - Venezuela 7
ZA - Sudafrica 6
ID - Indonesia 5
IE - Irlanda 5
UA - Ucraina 5
AU - Australia 4
CO - Colombia 4
DZ - Algeria 4
EC - Ecuador 4
PH - Filippine 4
PK - Pakistan 4
RU - Federazione Russa 4
AT - Austria 3
CL - Cile 3
CR - Costa Rica 3
EG - Egitto 3
ES - Italia 3
MA - Marocco 3
PY - Paraguay 3
DO - Repubblica Dominicana 2
JO - Giordania 2
LT - Lituania 2
PL - Polonia 2
PT - Portogallo 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BE - Belgio 1
IL - Israele 1
KE - Kenya 1
KG - Kirghizistan 1
KY - Cayman, isole 1
LB - Libano 1
NG - Nigeria 1
NI - Nicaragua 1
NP - Nepal 1
OM - Oman 1
PE - Perù 1
PF - Polinesia Francese 1
PR - Porto Rico 1
RO - Romania 1
RS - Serbia 1
SI - Slovenia 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
UZ - Uzbekistan 1
YT - Mayotte 1
Totale 15.384
Salva come PNG Salva come JPEG
Città #
Genova 7.961
Genoa 3.348
Rapallo 1.087
Vado Ligure 853
Singapore 308
San Jose 212
Lauterbourg 105
Ho Chi Minh City 55
Hanoi 40
Beijing 39
Hong Kong 36
New York 36
Council Bluffs 33
Ashburn 30
Helsinki 29
Santa Clara 23
Zurich 21
Bordighera 20
Frankfurt am Main 19
Tokyo 11
São Paulo 10
Los Angeles 9
Orem 9
Da Nang 7
Mexico City 7
Amsterdam 6
Baghdad 5
City of London 5
Dublin 5
Tianjin 5
Buenos Aires 4
Nuremberg 4
Sydney 4
Biên Hòa 3
Cazzago San Martino 3
Duhok 3
Florence 3
Haiphong 3
Milan 3
Rome 3
San José 3
Shanghai 3
Toronto 3
Barquisimeto 2
Bogotá 2
Bratislava 2
Bắc Ninh 2
Cairo 2
Cape Town 2
Caracas 2
Chennai 2
Chicago 2
Des Moines 2
Durban 2
Fortaleza 2
Goiânia 2
Guangzhou 2
Hải Dương 2
Jakarta 2
Jeddah 2
Kyiv 2
Lahore 2
Lisbon 2
Madrid 2
Manchester 2
Mosul 2
Naples 2
Posadas 2
Ribeirão Preto 2
Rio de Janeiro 2
San Juan 2
Santiago 2
Santo André 2
Thái Nguyên 2
Turin 2
Verona 2
Vũng Tàu 2
Zhengzhou 2
Acalanes Ridge 1
Acari 1
Acarigua 1
Alexandria 1
Algiers 1
Amman 1
Aracaju 1
Arica 1
Atlanta 1
Bab Ezzouar 1
Banfield 1
Bari 1
Barinas 1
Barra do Piraí 1
Basra 1
Belgrade 1
Bellflower 1
Berlin 1
Boa Esperança 1
Boardman 1
Brantford 1
Brasília 1
Totale 14.468
Salva come PNG Salva come JPEG
Nome #
Clinical characteristics, management and in-hospital mortality of patients with COVID-19 In Genoa, Italy 321
Left ventricular dilatation and subclinical renal damage in primary hypertension 248
Metabolic syndrome is associated with left ventricular dilatation in primary hypertension 205
Chronic kidney disease in hypertension under specialist care: the I-DEMAND study 193
Ambulatory arterial stiffness index and renal abnormalities in primary hypertension 192
Peripheral artery disease and blood pressure profile abnormalities in hemodialysis patients 190
Prevalence and prognostic value of cardiac troponin in elderly patients hospitalized for COVID-19 187
Chronic intake of micrograms of abscisic acid improves glycemia and lipidemia in a human study and in high-glucose fed mice 183
Increased renal resistive index in patients with essential hypertension: a marker of target organ damage. 182
C-reactive protein and target organ damage in untreated patients with primary hypertension. 176
5,10-Methylenetetrahydrofolate reductase polymorphism and early organ damage in primary hypertension. 175
Antihypertensive Treatment and Renal Protection: the role of drugs inhibiting the renin-angiotensin-aldosterone system. 174
Prevalence and Clinical Significance of Persistent Viral Shedding in Hospitalized Adult Patients with SARS-CoV-2 Infection: A Prospective Observational Study 173
Cardiovascular and renal effects of hyperuricaemia and gout. 172
Antihypertensive treatment and renal protection: Is there a J-curve relationship? 171
Changes in renal resistive index and urinary albumin excretion in hypertensive patients under long-term treatment with lisinopril or nifedipine GITS 166
Antihypertensive Treatment in Diabetic Kidney Disease: The Need for a Patient-Centered Approach 164
Clinical characteristics, management and in-hospital mortality of patients with coronavirus disease 2019 in Genoa, Italy 163
Blood pressure variability and multiple organ damage in primary hypertension 162
Mild hyperuricemia and subclinical renal damage in untreated primary hypertension 162
Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients 161
Subclinical functional and structural renal abnormalities predict new onset type 2 diabetes in patients with primary hypertension 161
Impact of target organ damage assessment in the evaluation of global risk in patients with essential hypertension. 159
Creatinine clearance and early signs of target organ damage in primary hypertension 152
Vitamin D modulates the association of circulating insulin-like growth factor-1 with carotid artery intima-media thickness 151
Elderly Woman With Abnormal ECG 151
Sub-clinical organ damage in hypertension and obesity 149
Combined effect of albuminuria and estimated glomerular filtration rate on cardiovascular events and all-cause mortality in uncomplicated hypertensive patients 148
Microalbuminuria identifies overall cardiovascular risk in essential hypertension: an artificial neural network-based approach. 148
Renal and cardiac abnormalities in primary hypertension 148
Combined use of urinary neutrophil gelatinase-associated lipocalin (uNGAL) and albumin as markers of early cardiac damage in primary hypertension. 148
Metabolic syndrome is associated with early signs of organ damage in nondiabetic, hypertensive patients 148
Increased ambulatory arterial stiffness index is associated with target organ damage in primary hypertension 147
Vitamin D increases circulating IGF1 in adults: potential implication for the treatment of GH deficiency 147
Inappropriate left ventricular mass is associated with microalbuminuria independently of left ventricular hypertrophy in primary hypertension 147
Predicting cardiovascular risk using creatinine clearance and an artificial neural network in primary hypertension 147
Use of nifedipine in the treatment of hypertension. 145
Coronary flow reserve is impaired in hypertensive patients with subclinical renal damage 145
Mild renal dysfunction and renal vascular resistance in primary hypertension 144
Hyperuricemia and renal risk 144
Metabolic syndrome and ambulatory arterial stiffness index in non-diabetic patients with primary hypertension. 143
METABOLIC SYNDROME AND CARDIOVASCULAR RISK IN PRIMARY HYPERTENSION. 142
Extensive activation, tissue trafficking, turnover and functional impairment of NK cells in COVID-19 patients at disease onset associates with subsequent disease severity 141
Evaluation of subclinical organ damage for risk assessment and treatment in the hypertensive patient: role of microalbuminuria. 140
Overall health assessment: a renal perspective. 140
Microalbuminuria and subclinical cerebrovascular damage in essential hypertension 138
7A.09: METABOLIC SYNDROME IS ASSOCIATED WITH LEFT VENTRICULAR DILATATION IN PRIMARY HYPERTENSION 138
Genetic polymorphism of the renin-angiotensin system and organ damage in essential hypertension 137
Severe vitamin D deficiency is associated with frequently observed diseases in medical inpatients 137
Increased urine semaphorin-3A is associated with renal damage in hypertensive patients with chronic kidney disease: a nested case-control study 137
Chronic kidney disease and albuminuria in arterial hypertension. 136
Cardiovascular and renal risk assessment as a guide for treatment in primary hypertension. 134
Uric acid lowering for slowing CKD progression after the CKD-FIX trial: a solved question or still a dilemma? 133
Mild renal dysfunction and cardiovascular risk in hypertensive patients. 133
Global Cardiovascular Risk Assessment in the Management of Primary Hypertension: The Role of the Kidney 133
A very low vitamin D threshold, within the range of severe deficiency, identifies an increased risk of non-classical vitamin D-related outcomes in medical inpatients: a role for parathyroid hormone? 132
Serum uric acid as a marker of target organ damage in primary hypertension 131
RAAS Inhibition and Renal Protection 130
SERUM URIC ACID AS A RISK FACTOR FOR CARDIOVASCULAR AND RENAL DISEASE AN OLD CONTROVERSY REVIVED. 130
Role of microalbuminuria in the assessment of cardiovascular risk in essential hypertension 130
Dyspnoea after home improvement work 130
Antihypertensive therapy in hypertensive patients with metabolic syndrome. 129
MICROALBUMINURIA, CARDIOVASCULAR, AND RENAL RISK IN PRIMARY HYPERTENSION. 126
Serum uric acid levels predict new onset type 2 diabetes in hospitalized patients with primary hypertension: the MAGIC study. 126
Global risk stratification in primary hypertension: the role of the kidney 125
Target organ damage and metabolic syndrome in non diabetic hypertensive patients 124
Metabolic syndrome and microalbuminuria predict renal outcome in non-diabetic patients with primary hypertension: the MAGIC study. 124
Microalbuminuria is a predictor of chronic renal insufficiency in patients without diabetes and with hypertension: the MAGIC Study 123
Creatinine clearance and signs of end-organ damage in primary hypertension. 123
Effects of dual inhibition of renin–angiotensin–aldosterone system on cardiovascular and renal outcomes: balancing the risks and the benefits 122
Blood pressure load, vascular permeability and target organ damage in primary hypertension 121
Metabolic syndrome and chronic kidney disease in high-risk Italian hypertensive patients: the I-DEMAND study. 121
Microalbuminuria and cardiovascular risk assessment in primary hypertension: should threshold levels be revised? 121
Optimizing therapy in the diabetic patient with renal disease: antihypertensive treatment. 121
Vascular permeability, blood pressure, and organ damage in primary hypertension 121
Coronary flow reserve is impaired in uncomplicated hypertensive patients with renal dysfunction 120
Association of uric acid with kidney function and albuminuria: the Uric Acid Right for heArt Health (URRAH) Project 120
Pulse pressure and subclinical cardiovascular damage in primary hypertension 118
Left ventricular geometry and function in patients with essential hypertension and microalbuminuria 117
Microalbuminuria blood pressure load, and systemic vascular permeability in primary hypertension 116
Mild renal dysfunction and subclinical cardiovascular damage in primary hypertension. 115
Relationship between inter-arm difference in systolic blood pressure and arterial stiffness in community-dwelling older adults. 115
Blood pressure phenotype: an evolving picture 115
Relationship between vitamin D status and left ventricular geometry in a healthy population: results from the Baltimore Longitudinal Study of Aging 115
Cardionephrology, an emerging discipline: Highlights of the sixth Genoa meeting on hypertension, diabetes and renal diseaseTherapy 112
Chronic kidney disease in the hypertensive patient: an overview of the I-DEMAND study. 110
Microalbuminuria in primary hypertension 110
Mild hyperuricemia and sub-clinical renal damage in primary hypertension 107
Microalbuminuria is an integrated marker of subclinical organ damage in primary hypertension. 106
Serum IGF-I concentration is positively associated with 25-hydroxyvitamin D level and increases upon treatment with vitamin D. 105
Serum uric acid and target organ damage in primary hypertension. 103
Serum uric acid and its relationship with metabolic syndrome and cardiovascular risk profile in patients with hypertension: insights from the I-DEMAND study 102
Mild renal dysfunction and subclinical organ damage in primary hypertension 101
Fructose and uric acid: Major mediators of cardiovascular disease risk starting at pediatric age 101
Looking at the kidney to predict global outcome in the elderly 99
MICROALBUMINURIA PREDICTS CHRONIC RENAL INSUFFICIENCY IN NON DIABETIC HYPERTENSIVE PATIENTS: THE MAGIC STUDY LONG TERM FOLLOW UP JOURNAL OF HYPERTENSION 98
Optimizing global risk evaluation in primary hypertension: the role of microalbuminuria and cardiovascular ultrasonography. 98
Kidney disease and all-cause mortality in patients with COVID-19 hospitalized in Genoa, Northern Italy 94
Improving cardiovascular risk stratification: the case for redefining microalbuminuria. 94
Micro-albuminuria reflects blood pressure load and systemic vascular permeability in primary hypertension 92
Totale 14.004
Salva come PNG Salva come JPEG
Categoria #
all - tutte 50.028
article - articoli 49.236
book - libri 0
conference - conferenze 671
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 121
Totale 100.056
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021280 0 0 0 0 0 0 0 0 0 107 82 91
2021/20221.399 49 82 77 169 54 120 105 324 45 146 58 170
2022/20231.346 128 81 12 146 195 233 41 93 215 53 106 43
2023/2024705 42 83 19 78 71 124 33 43 43 8 55 106
2024/20252.259 55 165 68 143 292 220 232 361 110 118 251 244
2025/20263.160 439 117 252 338 409 341 602 159 217 286 0 0
Totale 15.622